NBIX Neurocrine Biosciences Inc
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
Market Value*
$9.52B
Revenue (FY)
$2.86B 2025-12-31
Net Income (FY)
$478.60M
P/E (float-based)
19.9
American biopharmaceutical company.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
American biopharmaceutical company.